LY-2484595
|
|
|
- CAS-Nr.
- 1186486-62-3
- Englisch Name:
- LY-2484595
- Synonyma:
- SW-86;CS-653;SWF-86;LY-2484595;Evacetrapib;Evacetrapib, >=98%;LY-2484595 USP/EP/BP;LY-2484595 Evacetrapib;Evacetrapib (LY2484595);LY2484595; LY 2484595; LY-2484595
- CBNumber:
- CB82516031
- Summenformel:
- C31H36F6N6O2
- Molgewicht:
- 638.65
- MOL-Datei:
- 1186486-62-3.mol
|
LY-2484595 Eigenschaften
- Siedepunkt:
- 680.1±65.0 °C(Predicted)
- Dichte
- 1.40
- storage temp.
- Store at -20°C
- L?slichkeit
- ≥32.1 mg/mL in DMSO; insoluble in H2O; ≥50.4 mg/mL in EtOH with ultrasonic
- pka
- 4.73±0.10(Predicted)
- Aggregatzustand
- solid
- Farbe
- White to light yellow
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
LY-2484595 Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
Evacetrapib is an inhibitor of?cholesteryl ester transfer protein (CETP). CETP catalyzes the exchange of cholesteryl ester and triglyceride between lipoproteins and modulates HDL cholesterol levels in plasma. CETP inhibitors are potential compounds for treating coronary artery disease.
LY-2484595 Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
LY-2484595 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 120)Lieferanten
1186486-62-3()Verwandte Suche:
- LY-2484595
- Evacetrapib
- trans-4-[[(5S)-5-[[[3,5-Bis(trifluoromethyl)phenyl]methyl](2-methyl-2H-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1H-1-benzazepin-1-yl]methyl]cyclohexanecarboxylic acid
- (1S,4r)-4-(((S)-5-((3,5-bis(trifluoroMethyl)benzyl)(2-Methyl-2H-tetrazol-5-yl)aMino)-7,9-diMethyl-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl)Methyl)cyclohexanecarboxylic acid
- Evacetrapib (LY2484595)
- Cyclohexanecarboxylic acid, 4-[[(5S)-5-[[[3,5-bis(trifluoroMethyl)phenyl]Methyl](2-Methyl-2H-tetrazol-5-yl)aMino]-2,3,4,5-tetrahydro-7,9-diMethyl-1H-1-benzazepin-1-yl]Methyl]-, trans-
- Evacetrapib, >=98%
- EVACETRAPIB (LY2484595);LY2484595;LY 2484595;LY-2484595
- (1S,4r)-4-(((S)-5-((3,5-Bis(trifluoromethyl)benzyl)(2-methyl-2H-tetrazol-5-yl)amino)-7,9-dimet
- LY-2484595 Evacetrapib
- LY2484595; LY 2484595; LY-2484595
- 4-[[(5S)-5-[[3,5-bis(trifluoromethyl)phenyl]methyl-(2-methyltetrazol-5-yl)amino]-7,9-dimethyl-2,3,4,5-tetrahydro-1-benzazepin-1-yl]methyl]cyclohexane-1-carboxylicacid
- CS-653
- LY-2484595 USP/EP/BP
- SWF-86
- SW-86
- 4-trans-(((S)-5-((3,5-Bis(trifluoromethyl)benzyl)(2-methyl-2H-tetrazol-5-yl)amino)-7,9-dimethyl-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl)methyl)cyclohexanecarboxylic acid
- 1186486-62-3
- C31H36F6N6O2
- Inhibitors
- Inhibitor
